Study genes and cancer risk in uterine birth differences
Part of Cancer, Genetic & congenital, Women’s health & pregnancy clinical trials.
This study looks at how genetic factors and environment may relate to cancer risk in people with uterine birth differences. It also aims to improve clinical care by learning what patterns show up in real-world patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are female
- You are age 13 or older
- You receive care at one of these hospitals: Yale New Haven, Bridgeport, Greenwich, or Lawrence+ Memorial
- You have been diagnosed with a uterine birth difference (called a congenital uterine anomaly)
- You are willing to participate if the study contacts you
- You can complete consent/assent (agreement to join) and you can speak English or Spanish
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study combines routine obstetrical carrier screening with hereditary cancer risk screening in one blood draw. It aims to see if offering both tests together is feasible and helpful for patients receiving OB care.
This study looks at how certain uterine (womb) variations affect diagnosis, treatment choices, and reproductive outcomes. It may help doctors better understand these conditions and improve care for affected women.
This study looks at pregnancies that are considered high-risk because the baby is affected by a difference found during pregnancy or at birth. It may help researchers understand and improve care for families dealing with these fetal (baby) anomalies.
This study looks at reproductive health in women who have a specific type of uterus variation. It may help doctors understand diagnosis and treatment options and how these conditions affect fertility and daily health.
This study looks at people who have rare or unusual cancers or who may have an inherited (family) risk for cancer. It helps researchers learn what genetic or other factors might be involved by collecting family history and medical records, including pathology slides.
This study looks at why people with uterine cancer choose to join clinical trials. It aims to make future research easier and better informed.
Hear when a new Congenital Uterine Anomaly trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.